Ticker: CGC

Canopy Growth Corporation

Healthcare Healthcare Drug Manufacturers - Specialty & Generic
Price 0.89
Reco Sell Potential 10 Risk 85 Updated 2026-07-27

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

Canopy Growth Corporation is a Canadian cannabis company focused on the production and sale of cannabis and cannabis-related products. Its core offerings include dried flower, oils, and edibles, primarily targeting both recreational and medical markets. The company operates through various segments, including adult-use cannabis, medical cannabis, and international markets. Major revenue sources stem from product sales in these segments, with a growing emphasis on international expansion.

Investment Profile

The investment profile of Canopy Growth Corporation is more aligned with growth investors, given its focus on expanding market presence and product offerings despite current financial challenges. The company does not provide dividends, and its recent performance indicates a higher risk profile. Investors may consider a medium to long-term horizon for potential recovery and growth.

Fundamental metrics (experimental) Updated: 2026-07-27
EPS (TTM) — earnings per share for the last 12 months, $
-0.88
Revenue QoQ — quarter-over-quarter revenue growth
-30.3%
EPS surprise
-1556.0%
20d volatility
1.9%
AI recommendation changes
Date Before After Reason
2026-05-22 Hold Sell Weak fundamentals and negative momentum raise significant concerns.
2026-05-08 Hold Weak fundamentals and negative momentum raise significant concerns.
2026-05-08 Hold Hold Компания демонстрирует отрицательный EPS и высокую волатильность, что указывает на значительные риски. Несмотря на небольшой рост выручки, общая финансовая ситуация остается нестабильной.
News Page 1 of 1

Nothing yet